+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Aortic Stent Grafts Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 190 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716031
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aortic stent graft market presents complex opportunities for senior healthcare and medtech leaders, driven by innovation in intervention methods, evolving clinical practices, and fast-changing regulatory scenarios. Strategic clarity and current intelligence are essential for organizations navigating this growing sector and its patient-centric priorities.

Market Snapshot: Aortic Stent Graft Market Overview 

The aortic stent graft market reached an estimated USD 1.06 billion in 2024, underscoring robust expansion at a compound annual growth rate (CAGR) of 6.62%. Advancements in device design and increasing adoption of minimally invasive vascular procedures drive sustained demand and adoption. Innovations in imaging and surgical planning have enabled greater accuracy and customization, positioning manufacturers and healthcare providers to meet diverse patient needs efficiently. Market leaders are actively integrating new capabilities to enhance device reach for a broad spectrum of clinical environments across both developed and emerging regions. This growing landscape is shaped by adaptive strategies that support patient care as well as dynamic regulatory and competitive pressures.

Scope & Segmentation: Comprehensive Analysis of the Aortic Stent Graft Market

  • Aneurysm Location: Products tailored for abdominal, thoracic, and thoracoabdominal applications support clinicians addressing a wide variety of aortic pathologies in heterogeneous patient groups.
  • Graft Type: Branched, fenestrated, and standard stent grafts allow practitioners to align treatment selection with anatomical and procedural demands across the treatment continuum.
  • Configuration: Aorto-uni-iliac, bifurcated, and cuff graft configurations deliver procedural flexibility, enabling solutions for both routine and complex cases.
  • Deployment Mechanism: Availability of balloon-expandable and self-expanding systems provides clinical teams with options to optimize device fit within existing workflows and patient-specific contexts.
  • End User: Hospitals and ambulatory surgical centers serve as key deployment settings, leveraging specialist expertise and infrastructure for optimum device performance and patient outcomes.
  • Access Route: Iliac and transfemoral procedural approaches shape immediate results and inform longer-term care planning, enabling tailored intervention strategies.
  • Material: Use of expanded polytetrafluoroethylene and polyester promotes device durability and biocompatibility, supporting high standards of procedural safety and efficacy.
  • Geographical Coverage: The market spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, each region presenting unique regulatory, reimbursement, and care delivery frameworks that require nuanced market entry and expansion strategies.
  • Key Companies: Industry players such as Medtronic plc, W. L. Gore & Associates, Terumo Corporation, and Cook Medical LLC maintain competitive momentum by adapting solutions to diverse healthcare markets and responding to evolving clinical needs.

Aortic Stent Graft Market: Key Takeaways for Senior Decision-Makers

  • Advanced imaging and planning technologies are enhancing clinician ability to individualize interventions and improve outcomes, particularly in complex aortic procedures.
  • Market dynamics are significantly influenced by variations in reimbursement systems and healthcare structures, requiring strategies that adapt to local regulatory and operational realities.
  • Frequent supply chain disruptions and evolving policy environments highlight the importance of timely market intelligence and flexible risk mitigation planning across global device distribution.
  • Active collaboration between manufacturers and clinical stakeholders is central to effective integration of new technology and achieving routine adoption in specialized care settings.
  • Robust post-market surveillance and periodic product updates are crucial for abiding by regulatory requirements and maintaining confidence among clinical and regulatory decision-makers.
  • Continuous investment in clinician training enables safe, effective deployment of advanced stent grafts as technology complexity and care ecosystem demands rise.

Assessing Tariff Impact—Operational and Strategic Implications

Forthcoming U.S. tariffs on imported medical devices in 2025 are set to increase cost pressures on aortic stent graft manufacturers. In anticipation, organizations are optimizing sourcing and production strategies while maintaining close regulatory engagement to manage expense exposure. Healthcare providers and distribution partners are now revising inventory controls to minimize price fluctuations and ensure reliable patient access to essential vascular devices. Ongoing adaptability and sound logistics management are now central to organizational resilience amid continued market uncertainty.

Methodology & Data Sources

This market review draws from first-hand input by clinicians, device engineers, and procurement specialists, along with validated industry sources. All results are benchmarked against the latest clinical practice and market standards, equipping senior leadership with intelligence for informed and risk-ready decisions.

Why This Report Matters for Industry Leaders

  • Aligns product development, operational planning, and investment activities with shifting clinical, regulatory, and market needs.
  • Strengthens planning and execution for regional market entry, compliance alignment, and resource optimization in complex healthcare landscapes.
  • Enables risk anticipation and business continuity for reliable vascular device supply and distribution.

Conclusion

Strategic leadership and timely intelligence are essential for organizations seeking sustainable advantage in the evolving aortic stent graft market. Proactive, coordinated adaptation prepares enterprises to meet changing market and regulatory expectations with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Growing adoption of single-branch and dual-branch endovascular grafts for thoracoabdominal aneurysms
5.2. Integration of advanced imaging modalities and 3D printing for personalized stent graft planning
5.3. Rising demand for low-profile delivery systems to treat patients with small access vessels
5.4. Development of bioresorbable and polymer-coated stent grafts to reduce long-term complications
5.5. Expansion of remote monitoring and telehealth solutions for postoperative surveillance of endograft patients
5.6. Increasing collaborations between device manufacturers and research institutions for next generation endografts
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Aortic Stent Grafts Market, by Aneurysm Location
8.1. Abdominal Aortic Aneurysm
8.1.1. Elective Repair
8.1.2. Emergency Repair
8.2. Thoracic Aortic Aneurysm
8.2.1. Elective Repair
8.2.2. Emergency Repair
8.3. Thoracoabdominal Aortic Aneurysm
8.3.1. Elective Repair
8.3.2. Emergency Repair
9. Aortic Stent Grafts Market, by Graft Type
9.1. Branched Stent Graft
9.2. Fenestrated Stent Graft
9.3. Standard Stent Graft
10. Aortic Stent Grafts Market, by Configuration
10.1. Aorto-Uni-Iliac
10.2. Bifurcated
10.3. Cuff
11. Aortic Stent Grafts Market, by Deployment Mechanism
11.1. Balloon Expandable
11.2. Self Expanding
12. Aortic Stent Grafts Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
13. Aortic Stent Grafts Market, by Access Route
13.1. Iliac
13.2. Transfemoral
14. Aortic Stent Grafts Market, by Material
14.1. Expanded Polytetrafluoroethylene
14.2. Polyester
15. Aortic Stent Grafts Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Aortic Stent Grafts Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Aortic Stent Grafts Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Medtronic plc
18.3.2. W. L. Gore & Associates, Inc.
18.3.3. Terumo Corporation
18.3.4. Cook Medical LLC
18.3.5. Bolton Medical Inc.
18.3.6. Lombard Medical Ltd
18.3.7. Jotec GmbH
18.3.8. B. Braun Melsungen AG
18.3.9. Boston Scientific Corporation
18.3.10. Endologix, Inc.

Companies Mentioned

The companies profiled in this Aortic Stent Grafts market report include:
  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • Bolton Medical Inc.
  • Lombard Medical Ltd
  • Jotec GmbH
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Endologix, Inc.

Table Information